Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
Clinical trial NCT00003230 · COMPLETED
Trial details
- NCT number
- NCT00003230
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-01-01
- Primary completion
- 2000-07-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.